论文部分内容阅读
青光眼是继白内障之后世界范围内第二位的致盲眼病,同时也是最常见的不可逆性致盲眼病,青光眼肓的严峻形势正逐步凸现。我国是世界上最大的发展中国家,原发性闭角型青光眼(primary angle closure glaucoma,PACG)患病率较高,随着人口老龄化进程,PACG和“可关闭房角”的患者数量还将进一步增大。我国当前PACG防治模式面临着诸多问题,卫生资源匮乏且分布不均衡,缺乏符合我国国情的诊治规范,存在着过度治疗现象。本文针对当前PACG防治模式的特点和问题,从循证医学和卫生经济学双重角度作一阐述,并进一步对今后的临床与科研工作提出改进意见。
Glaucoma is the second blind disease in the world after cataract and is the most common irreversible eye disease. The severe situation of glaucoma is gradually emerging. China is the largest developing country in the world. The prevalence of primary angle closure glaucoma (PACG) is high. As the population ages, PACG and patients with “can close the angle” The number will further increase. At present, there are many problems in the prevention and control of PACG in our country. The health resources are scarce and distributed unevenly. There is a lack of treatment norms in line with China’s national conditions, and there is an over-treatment phenomenon. In view of the current characteristics and problems of PACG prevention and treatment mode, this article elaborates from the dual perspectives of evidence-based medicine and health economics, and puts forward suggestions for improvement in clinical and scientific research in the future.